Key Insights

Highlights

Treatment Research

2 treatments under study, led by Digoxin

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05540600Phase 3Unknown

Left Atrium Reservoir Function Modulation in Patients With Atrial Fibrillation: Digoxin Versus Beta Blocker

Showing all 1 trials

Research Network

Common Treatments

  • Digoxin1
  • Bisoprolol1

Active Sponsors

  • University of Monastir1

Top Investigators

Related Conditions

  • Atrial Fibrillation1

Activity Timeline